## ULTA: Ulta Beauty, Inc. - XLY: Consumer Cyclical

### Executive Summary

STRENGTH thesis confirmed: MRS_10 at 3.7% in lower entry zone (3.0-6.0%), top quartile (76th pct) cross-sectional ranking. Caution: MRS_5 (-0.7%) diverging from MRS_10, watch for reversal. Outperforming sector by 2.7%. Caution: momentum weakening (-5.9% MRS).

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($553.01)
- **If Wrong:** Exit if MRS_10 drops below entry zone or breaks stop
- **Invalidation:** MRS_10 exits entry zone or MRS_5 turns negative

### News

- **Articles:** 9
- **Sentiment:** Bullish (Bullish: 7, Bearish: 0)

**1. Flower Knows Expands U.S. Retail Distribution By Entering Ulta Beauty**
- Source: PR Newswire | 20251209T130844 | Bullish | Relevance: 99%
- Flower Knows, a global cosmetics brand known for its vibrant and whimsical products, is significantly expanding its U.S. retail presence by debuting on Ulta.com as of December 7, 2025. This marks a major milestone in their international growth, making the U.S. their largest overseas market. The brand, which boasts millions of social media followers and celebrity endorsements, will offer 62 products across various categories and themed collections, ranging from $8-$45.

**2. Is Ulta Beauty Stock Outperforming the Dow?**
- Source: Markets Financial Content | 20251211T063500 | Bullish | Relevance: 99%
-  Ulta Beauty, Inc. (ULTA) has shown strong performance, with its stock rising 16.5% over the past three months and 45.8% over the past 52 weeks, significantly outperforming the Dow Jones Industrials Average. The company's success is attributed to enhanced in-store experiences, an expanding loyalty program, exclusive brand launches, and robust e-commerce growth. Analysts maintain a "Moderate Buy" rating, anticipating further upside for the stock.

**3. Is Ulta Beauty Stock Outperforming the Dow?**
- Source: Barchart.com | 20251211T113834 | Bullish | Relevance: 99%
-  Ulta Beauty Inc. (ULTA) has significantly outperformed the Dow Jones Industrials Average ($DOWI) over the past three months, six months, and the last 52 weeks. The company's strong performance is attributed to enhanced in-store experiences, an expanding loyalty program, exclusive brand launches, and robust e-commerce growth, while analysts maintain a "Moderate Buy" rating with a potential upside.

**4. Ulta Beauty Counters Rivals With Advantages in Product Selection, Stores, and Loyalty**
- Source: Morningstar | 20251210T220834 | Bullish | Relevance: 98%
- Ulta Beauty maintains a narrow economic moat through its strong brand, extensive product selection, and a successful loyalty program with over 45 million members. The company has significantly increased its revenue and store count over the past decade, effectively competing against both mall-based retailers and e-commerce giants like Amazon. Ulta's strategy leverages in-store experiences, salons, and promotions to encourage frequent customer visits and drive market share.

**5. Ulta Beauty (ULTA) Valuation Check After Q3 Earnings Beat and Upgraded Full-Year Guidance**
- Source: Yahoo Finance | 20251210T231856 | Bullish | Relevance: 98%
- Ulta Beauty (ULTA) exceeded expectations in its Q3 earnings, beating sales and earnings while also increasing full-year guidance, which boosted the stock's outlook. Despite a significant 40% year-to-date share price return and a 120% five-year total shareholder return, the stock is currently trading around analyst targets. While a narrative fair value suggests it's "ABOUT RIGHT" at $603 due to growth potential, a price-to-earnings lens indicates it's expensive at 22.5 times earnings compared to a 17.9 fair ratio.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 13, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-10 | Oppenheimer | $675 | $615 | +10% |
| 2025-12-08 | Morgan Stanley | $640 | $600 | +7% |
| 2025-12-08 | TD Cowen | $725 | $600 | +21% |
| 2025-12-05 | DA Davidson | $650 | $625 | +4% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-10 | Oppenheimer | main | Outperform |
| 2025-12-08 | Morgan Stanley | main | Overweight |
| 2025-12-08 | TD Cowen | up | Buy |
| 2025-12-05 | DA Davidson | main | Buy |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 45.9% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 12.1% (+0.6%)
- Blackrock Inc.: 9.0% (-2.1%)
- JPMORGAN CHASE & CO: 5.5% (+99.0%)
- State Street Corpora: 4.4% (+2.3%)
- Sanders Capital, LLC: 2.8% (+8.9%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Analyst target momentum: 13 raises (avg +6%) could attract flows.
- AI/machine learning initiatives could drive multiple expansion if executed.

### Fundamentals

PEG ratio 2.42 elevated, pricing in significant growth expectations. Forward P/E 21.1x stretched relative to 10% growth. Quality metrics strong (ROE 48%, ROA 15%). Analyst sentiment positive (13 raises, avg +6%). Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $26.6B |
| Beta | 0.87 |
| 52W Range | $309.01 - $611.90 |
| Short Interest | 6.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.42 |
| Forward P/E | 21.1 |
| Current P/E | 23.3 |
| YoY Growth | 10.4% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from 9.6% to 3.7% (-5.9% in 5 days), indicating relative weakness vs NASDAQ. Currently in lower STRENGTH zone (3.0-6.0%), cross-sectional ranking at 76th percentile. MRS_5 (-0.7%) diverging from MRS_10 - short-term weakness emerging. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (8.02), confirming momentum.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 3.68% (CS: 77) | Strong |
| RSI_14 | 66.3 | Neutral |
| MACD Histogram | 8.02 | Bullish |
| vs SMA20 | 1.093x | Above |
| vs SMA50 | 1.106x | Above |
| vs SMA200 | 1.264x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $593.41
- **Stop Loss:** $553.01 (6.8% risk)
- **Target:** $654.01 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 34
- **Position Value:** $20,175.94
- **Portfolio %:** 20.18%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX at low 8th percentile signals complacency, but decent breadth and positive yield curve support selective positioning. Focus on quality names with earnings visibility.*

### Earnings

**Next:** 2026-03-12 (Est: $7.15)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $4.60 | $5.14 | +11.7% |
| 2025Q3 | $5.04 | $5.78 | +14.6% |
| 2025Q2 | $5.80 | $6.70 | +15.5% |
| 2025Q1 | $7.15 | $8.46 | +18.4% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*